Mammalian drug resistant mutants with multiple gene amplifications: Genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin and the L-subunit of ferritin

UNIV MANITOBA,MANITOBA INST CELL BIOL,100 OLIVIA ST,WINNIPEG R3E 0V9,MANITOBA,CANADA. UNIV MANITOBA,DEPT INTERNAL MED,WINNIPEG R3E 0V9,MANITOBA,CANADA. UNIV MANITOBA,DEPT BIOCHEM,WINNIPEG R3E 0V9,MANITOBA,CANADA. UNIV MANITOBA,DEPT MICROBIOL,WIN(TRUNCATED)

AMSTERDAM; PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS

ELSEVIER SCIENCE BV

PT: J; CR: ASHIHARA J, 1979, METHOD ENZYMOL, V58, P259 AZIZ N, 1986, NUCLEIC ACIDS RES, V14, P915 BEAUMONT C, 1987, J BIOL CHEM, V262, P10619 BEAUMONT C, 1989, J BIOL CHEM, V264, P7498 BIN N, 1976, NUCLEIC ACIDS RES, V3, P2303 BLAKE MS, 1984, ANAL BIOCHEM, V136, P175 BOLIN RW, 1982, CANCER, V50, P1683 BOMFORD AB, 1985, HEPATOLOGY, V5, P870 CASEY JL, 1988, P NATL ACAD SCI USA, V85, P1787 CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294 CHOY BK, 1988, CANCER RES, V48, P2029 CHOY BK, 1989, BIOCHEM BIOPH RES CO, V162, P1417 COCKING JM, 1987, SOMAT CELL MOLEC GEN, V13, P221 DEBATISSE M, 1986, MOL CELL BIOL, V6, P1776 DONOVAN PB, 1984, AM J HEMATOL, V17, P329 ENGSTROM PF, 1984, AM J CLIN ONCOL-CANC, V7, P313 ENGSTROM Y, 1984, EMBO J, V3, P863 ERIKSSON S, 1981, J BIOL CHEM, V256, P9436 FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6 GRASLUND A, 1982, J BIOL CHEM, V257, P5711 HARDS RG, 1981, J CELL PHYSIOL, V106, P309 HOPPER S, 1972, J BIOL CHEM, V247, P3336 HURTA RAR, 1990, BIOCHEM BIOPH RES CO, V167, P258 KUHN LC, 1984, CELL, V39, P267 LAEMMLI UK, 1970, NATURE, V227, P680 LEIBOLD EA, 1984, J BIOL CHEM, V259, P4327 MADHUBALA R, 1987, FED PROC, V46, P2254 MCCLARTY GA, 1986, SOMAT CELL MOLEC GEN, V12, P121 MCCLARTY GA, 1987, BIOCHEMISTRY-US, V26, P8004 MCCLARTY GA, 1988, BIOCHEM BIOPH RES CO, V154, P975 MCCLARTY GA, 1988, BIOCHEMISTRY-US, V27, P7524 MCCLARTY GA, 1990, J BIOL CHEM, V265, P7539 MCDONALD CJ, 1981, PHARMACOL THERAPEUT, V14, P1 MURRAY MT, 1987, P NATL ACAD SCI USA, V84, P7438 PEGG AE, 1988, CANCER RES, V48, P759 PIVER MS, 1983, AM J OBSTET GYNECOL, V147, P803 POHJANPELTO P, 1985, MOL CELL BIOL, V5, P1385 ROUAULT TA, 1987, P NATL ACAD SCI USA, V84, P6335 SCHIMKE RT, 1984, CANCER RES, V44, P1735 SCHIMKE RT, 1988, J BIOL CHEM, V263, P5989 SRINIVASAN PR, 1987, J BIOL CHEM, V262, P12871 STARK GR, 1986, CANCER SURV, V5, P1 STARK GR, 1989, CELL, V57, P901 STEEPER JR, 1970, ANAL BIOCHEM, V34, P123 TAGGER AY, 1987, BIOCH CELL BIOL, V65, P925 TAGGER AY, 1988, INT J CANCER, V42, P760 THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289 THELANDER L, 1980, J BIOL CHEM, V255, P7426 THELANDER L, 1986, MOL CELL BIOL, V6, P3433 THELANDER M, 1985, J BIOL CHEM, V260, P2737 THOMAS CE, 1986, J BIOL CHEM, V261, P13064 TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350 WRIGHT JA, 1987, SOMAT CELL MOLEC GEN, V13, P155 WRIGHT JA, 1989, DRUG RESISTANCE MAMM, V1, P15 WRIGHT JA, 1989, INT ENCY PHARM THERA, V128, P89; NR: 55; TC: 25; J9: BIOCHIM BIOPHYS ACTA; PG: 8; GA: EH920

Source type: Electronic(1)